ImmPACT Bio

Imm Pact Bio

Biotechnology, 59 Lk Dr, West Hills, California, 08520, United States, 51-200 Employees

immpact-bio.com

  • LinkedIn

phone no Phone Number: 81********

Who is IMMPACT BIO

ImmPACT Bio is dedicated to the discovery of transformative CAR-T cell therapies for cancer patients who have exhausted their treatment options. Our technology is designed to precisely di...

Read More

map
  • 59 Lk Dr, West Hills, California, 08520, United States Headquarters: 59 Lk Dr, West Hills, California, 08520, United States
  • 2017 Date Founded: 2017
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from IMMPACT BIO

ImmPACT Bio Org Chart and Mapping

Employees

Sandani Silva

Quality Control Microbiology Manager

Meghan Carr

Manufacturing Supervisor

Carol Castaneda

Cell Therapy Specialist III

Todd Schmitt

Vice President, Clinical Development Operations

Ofir Goldberger

Executive Director, Corporate Development

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding ImmPACT Bio

Answer: ImmPACT Bio's headquarters are located at 59 Lk Dr, West Hills, California, 08520, United States

Answer: ImmPACT Bio's phone number is 81********

Answer: ImmPACT Bio's official website is https://immpact-bio.com

Answer: ImmPACT Bio's revenue is $25 Million to $50 Million

Answer: ImmPACT Bio's SIC: 2836

Answer: ImmPACT Bio's NAICS: 541714

Answer: ImmPACT Bio has 51-200 employees

Answer: ImmPACT Bio is in Biotechnology

Answer: ImmPACT Bio contact info: Phone number: 81******** Website: https://immpact-bio.com

Answer: ImmPACT Bio is dedicated to the discovery of transformative CAR-T cell therapies for cancer patients who have exhausted their treatment options. Our technology is designed to precisely distinguish cancerous cells from normal cells; thereby eliminating tumors without damaging normal tissues. Our goal is to eradicate tumors without generating the severe side effects that are difficult, sometimes impossible, for cancer patients to endure. The company was founded in 2017 in the FuturRx incubator (Israel). In 2019, ImmPACT Bio was incorporated in the US and R&D operations were established in Camarillo, CA. In 2021 ImmPACT Bio merged with Kalthera.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access